Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, remains a significant public health concern globally. This article aims to provide an overview of the latest advancements in the diagnosis and treatment of enteric fever.
Traditional diagnostic methods, such as blood cultures, have limitations including time-consumption and low sensitivity. Recent advancements include the development of molecular techniques like Polymerase Chain Reaction (PCR) and Loop-Mediated Isothermal Amplification (LAMP). These techniques offer higher sensitivity and specificity, and faster results, contributing to improved patient management.
Antimicrobial resistance has complicated the treatment of enteric fever. The introduction of newer antibiotics such as azithromycin and third-generation cephalosporins (e.g., ceftriaxone) has proven effective. Additionally, the resurgence of older antibiotics like chloramphenicol, following sensitivity restoration, demonstrates the dynamic nature of antimicrobial resistance.
Vaccination remains a cornerstone in the prevention of enteric fever. The World Health Organization (WHO) has endorsed the use of Typhoid Conjugate Vaccines (TCVs), given their longer-lasting immunity, suitability for children under two, and single-dose administration. This advancement has the potential to significantly reduce the global burden of enteric fever.
The fight against enteric fever is being bolstered by advancements in diagnostic techniques, treatment strategies, and preventive measures. Continued research and development are crucial to stay ahead of the evolving pathogen and antimicrobial resistance. As healthcare professionals, staying abreast of these advancements is essential to provide optimal patient care and contribute to global health improvement.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation